CAVALON THERAPEUTICS, INC.
The mission of Cavalon Therapeutics, Inc is to develop best in class medicines for neurodegenerative and neuropsychiatric diseases. Cavalon has established proprietary insights and drug development strategies based on an understanding of the role of plasma membrane calcium channels in CNS diseases. Our first therapeutic programs focus on breakthrough medicines for Parkinson’s disease and Opioid Use Disorder (OUD), two large markets with significant unmet needs. Cavalon was founded by an expe... rienced team of entrepreneurs and scientists from industry and academia. The company is built around discoveries made by Dr. James Surmeier, one of the company's co-founders, and Cavalon has access to key technology and intellectual property from Northwestern University. Cavalon Therapeutics is supported by grant funding from the Michael J. Fox Foundation for Parkinson's Research.
CAVALON THERAPEUTICS, INC.
Social Links:
Industry:
Biotechnology
Founded:
2020-05-01
Website Url:
http://www.cavalonthera.com
Status:
Active
Email Addresses:
[email protected]
Similar Organizations
Anagin
Anagin is developing first-in-class therapies for treating neuropsychiatric diseases.
Spinogenix
Spinogenix is a developer of a new class of therapeutics for neurodegenerative and psychiatric diseases.
Current Employees Featured
Founder
Official Site Inspections
http://www.cavalonthera.com
- Host name: 198.49.23.144
- IP address: 198.49.23.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Cavalon Therapeutics, Inc."
Cavalon Therapeutics, Inc. - Crunchbase Company Profile & Funding
Contact Email [email protected] The mission of Cavalon Therapeutics, Inc is to develop best in class medicines for neurodegenerative and neuropsychiatric diseases. Cavalon has …See details»
Cavalon Therapeutics, Inc. | LinkedIn
Cavalon Therapeutics, Inc. Biotechnology Research Berkeley, CA 86 followers Breakthrough Medicines for Neurodegenerative and Neuropsychiatric DiseasesSee details»
Cavalon Therapeutics, Inc. Overview | SignalHire Company Profile
The mission of Cavalon Therapeutics, Inc is to develop best in class medicines for neurodegenerative and neuropsychiatric diseases. Cavalon has established proprietary …See details»
Cavalon Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Cavalon Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
Cavalon Therapeutics - Overview, News & Similar companies
View Cavalon Therapeutics (www.cavalonthera.com) location in United States , revenue, industry and description. Find related and similar companies as well as employees by title and much …See details»
David O'Reilly - Chief Executive Officer - Crunchbase
David O’Reilly is an entrepreneur and executive in the life sciences industry with 30 years of experience in founding, financing and growing innovative pharmaceutical, medical device and …See details»
Blog 2 — Cavalon Therapeutics, Inc.
Cavalon and its collaborators have discovered in an analysis of a major NIH-funded Phase III clinical trial in Parkinson’s disease that patients who cleared a candidate medicine more slowly …See details»
Movement Disorders Publication — Cavalon Therapeutics, Inc.
Oct 1, 2021 Cavalon and its collaborators have discovered in an analysis of a major Michael J. Fox Foundation-funded Phase II clinical trial in Parkinson’s disease that patients taking an …See details»
AGAMREE® (vamorolone) – santhera
AGAMREE® (vamorolone) AGAMREE (vamorolone) is a first-in-class drug candidate that binds to the same receptors as corticosteroids but modifies the downstream activity of the receptors 1,2.This has the potential to ‘dissociate’ …See details»
Homepage | The LaRouche Organization
Dec. 2, 2024 (EIRNS)—The Schiller Institute International Online Conference, “In the Spirit of Schiller and Beethoven: All Men Become Brethren,” this Saturday, Dec. 7 and Sunday, Dec. 8, intersects the most dangerous …See details»
What Happened To Cavalia - Inckredible
Mar 30, 2024 Cavalia, the equestrian and performing arts company, has continued to evolve and expand its productions. Over the years, it has faced challenges like any other live …See details»
Planeterra – Turning Travel Into Impact
The Wish List is your chance to make a meaningful difference in communities worldwide. This holiday season, we invite you to support Planeterra and our work to create opportunities for …See details»
Cantiro | Formerly Beaverbrook Group of Companies & Dolce Vita …
1 day ago On October 1, 2020, the Beaverbrook Group of Companies (Dolce Vita, MODA, InHouse, Beaverbrook Communities, Beaverbrook Commercial) came together under one new …See details»
Commonwealth
The Commonwealth is a voluntary association of 56 independent and equal countries. It is home to 2.7 billion people, and includes both advanced economies and developing countries. 33 of …See details»
YGOrganization | Yu-Gi-Oh! news that ends misinformation
4 days ago YGOrganization is the world’s most reliable information source for all Yu-Gi-Oh! news and content.See details»
Osteoporosis Canada
Osteoporosis Canada, a registered charity, is the only national organization serving people who have, or are at risk for, osteoporosis. We work to educate, empower and support individuals …See details»
Free custom organization chart templates | Canva
Represent your company or team’s hierarchy in an appealing way with a free organization chart template by Canva. Whether you’re a large corporation or a new startup, a good organization …See details»
The Story Behind Cavalia, One of The Largest Shows on Earth
Cavalia is an entertainment company that specializes in the creation, production and touring of innovative shows, with horses being the main attraction.See details»
AmacaThera: Revolutionizing Pain Management | RBCx
Jun 12, 2024 Mike Cooke and Molly Shoichet are the co-founders of AmacaThera, a Toronto-based venture offering a novel way to provide pain relief without the use of opioids.Their …See details»